A very low incidence of BRAF mutations in Middle Eastern colorectal carcinoma
2014 · Molecular Cancer · 40 citations
https://doi.org/10.1186/1476-4598-13-168
S
Shaham Beg
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
83
Papers
1.1K
Citations
19
h-index
27
i10-index
Shaham Beg is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Thyroid Cancer Diagnosis and Treatment & Genetic factors in colorectal cancer & Cell death mechanisms and regulation. The author has an h-index of 19, co-authored 71 publications.
ORCID: 0000-0002-6068-1595Papers by this author
worksCo-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells
2015 · Molecular Cancer · 39 citations
https://doi.org/10.1186/s12943-015-0406-1
PTEN loss is associated with follicular variant of Middle Eastern papillary thyroid carcinoma
2015 · British Journal of Cancer · 32 citations
https://doi.org/10.1038/bjc.2015.169
Fusions involving BCOR and CREBBP are rare events in infiltrating glioma
2020 · Acta Neuropathologica Communications · 25 citations
https://doi.org/10.1186/s40478-020-00951-4
Integration of whole-exome and anchored PCR-based next generation sequencing significantly increases detection of actionable alterations in precision oncology
2020 · Translational Oncology · 17 citations
https://doi.org/10.1016/j.tranon.2020.100944
The evolution of metastatic upper tract urothelial carcinoma through genomic-transcriptomic and single-cell protein markers analysis
2024 · Nature Communications · 10 citations
https://doi.org/10.1038/s41467-024-46320-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat